Executive Summary Pfizer has introduced a new platform called USTAT (Unified Sequential Template Amplification and Transcription). The platform uses Rolling Circle Amplification (RCA) to establish an mRNA manufacturing process that does not rely on traditional plasmid DNA. The time from DNA template generation to mRNA production can potentially be reduced to approximately two days. RNA quality approaches that of conventional plasmid DNA-based manufacturing, although challenge

Executive Summary Antibody drug conjugates (ADCs) have become one of the most important innovations in oncology and the broader biotech industry in recent years. Over the past decade, antibody drug conjugates have evolved from early-stage research tools into an integrated system spanning science, clinical development, manufacturing, and market strategy. Understanding ADCs solely from the perspective of molecular design or clinical efficacy is no longer sufficient. Antibody d